...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Validation of a probe for assessing deconjugation of glucuronide and sulfate phase II metabolites assayed through LC–MS/MS in biological matrices
【24h】

Validation of a probe for assessing deconjugation of glucuronide and sulfate phase II metabolites assayed through LC–MS/MS in biological matrices

机译:通过在生物基质中通过LC-MS / MS测定通过LC-MS / MS测定的葡糖和硫酸酯期代谢物的抑制探针

获取原文
获取原文并翻译 | 示例

摘要

Highlights ? For the first time development of an enzymatic deconjugation probe using LC–MS/MS. ? MU, MUG and MUS, used as markers, were assessed through LC–MS/MS. ? The assay has been validated according to current guidelines. ? Probe is suitable to assess the deconjugation efficiency of xenobiotic metabolites. Abstract LC–MS/MS has been proposed in various areas such as Therapeutic Drug Monitoring (TDM), Human Biomonitoring (HBM), disease diagnosis, clinical toxicology and doping control to identify and quantify chemical parents and their metabolites in biological matrices. To determine the total content of a xenobiotic (unconjugated+conjugated forms), an enzymatic hydrolysis step is required. Most studies in the literature have not controlled the effectiveness of the deconjugation process because no method has been described for that purpose. Therefore the aim of this study was to develop and validate a deconjugation probe using a LC–MS/MS method. In order to estimate deconjugation using β-glucuronidase and/or sulfatase, 4-methyl-umbelliferone (MU) and its conjugates were used as markers. Glucuronidase/sulfatase was added to plasma or urine spiked with 4-methylumbelliferyl-β-d-glucuronide (MUG) and 4-methylumbelliferyl sulfate (MUS) and umbelliferone, which was used as the internal standard. After incubation at 37°C during 90min, MU appears as a result of the deconjugation of MUG and MUS. The concentrations of the 3 markers were determined using LC–MS/MS. Trueness and precision of the LC–MS/MS method were determined by quality control analysis at three different levels of concentration covering the whole range of calibration. In both matrices, the analytical method allows quantification of the different compounds, with good linearity, trueness and precision and negligible matrix effects. The method was applied with success to deconjugation assay using active glucuronidase/sulfatase in plasma and urine. The probe developed in this study allows to ensure that enzymatic preparation is working properly in the frame of a quality system. ]]>
机译:highlights“view=”all“>首次使用LC–MS/MS开发酶解结合探针。MU、MUG和MU作为标记物,通过LC-MS/MS进行评估。分析已根据当前指南进行验证。探针适用于评估异源代谢物的去结合效率。摘要LC–MS/MS已在治疗性药物监测(TDM)、人类生物监测(HBM)等多个领域被提出,疾病诊断,临床毒理学和兴奋剂控制,以确定和量化生物基质中的化学亲本及其代谢物。为了确定异源化合物(未结合的+结合形式)的总含量,需要进行酶水解步骤。文献中的大多数研究都没有控制去共轭过程的有效性,因为没有为此目的描述任何方法。因此,本研究的目的是使用LC–MS/MS方法开发并验证去结合探针。为了使用β-葡萄糖醛酸酶和/或硫酸酯酶估计去结合,使用4-甲基伞形花序酮(MU)及其结合物作为标记将葡萄糖醛酸酶/硫酸酯酶添加到血浆或尿液中,加入4-甲基伞形花序基-β-d-葡萄糖醛酸苷(MUG)和4-甲基伞形花序基硫酸盐(MUS)和伞形花序酮作为内标。在37℃下培养90分钟后,MU出现,这是MUG和MUS去结合的结果。使用LC–MS/MS测定3种标记物的浓度。LC–MS/MS方法的真实性和精密度通过三种不同浓度水平的质量控制分析确定,涵盖整个校准范围在两种基质中,分析方法允许对不同化合物进行定量,具有良好的线性、真实性和精密度,且基质效应可以忽略不计。该方法已成功应用于血浆和尿液中活性葡萄糖醛酸酶/硫酸酯酶的去结合分析。本研究开发的探针可以确保酶制剂在质量体系框架内正常工作]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号